ISO 18362:2016

Current Revision
Manufacture of cell-based health care products - Control of microbial risks during processing

Best Price Guarantee Feb 1, 2016 English 1 Pages

Modifications (Amendments, Corrigenda, Errata, etc.)

Version PDF Print Bundle
Amendment 1 Stand-Alone
$23.10 $23.10 $39.27

Sub Total (1 Item(s)) $ 0.00
Estimated Shipping $ 0.00
Total (Pre-Tax) $ 0.00

You own the digital copy of this edition

View in Library
or
International Organization for Standardization Logo

ISO 18362:2016

Manufacture of cell-based health care products - Control of microbial risks during processing

PUBLISH DATE 2016
ISO 18362:2016

ISO 18362:2016 specifies the minimum requirements for, and provides guidance on, a risk-based approach for the processing of cell-based health care products (CBHPs) requiring control of viable and non-viable microbial contamination. It is applicable both to CBHPs labelled 'sterile' and to CBHPs not labelled 'sterile'.

ISO 18362:2016 is not applicable to:

  • procurement and transport of cell-based starting material used in processing of a CBHP,
  • cell banking,
  • control of genetic material,
  • control of non-microbial product contamination,
  • in vitro diagnostics (IVDs), or
  • natural medicines.

EXAMPLE Vitamins and minerals, herbal remedies, homoeopathic medicines, traditional medicines such as traditional Chinese medicines, probiotics, other products such as amino acids and essential fatty acids.

ISO 18362:2016 does not define biosafety containment requirements.

ISO 18362:2016 does not replace national or regional regulations that apply to the manufacture and quality control of a CBHP.

Loading...

Failed to load document history.

Publish Date Document Id Type View